Biotechnology Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value – Amgen (NASDAQ:AMGN) Read more
Biotechnology Avalo Therapeutics’ Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades – Avalo Therapeutics (NASDAQ:AVTX) Read more
Biotechnology Vertex’s Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept’s Potential Impact – Vertex Pharmaceuticals (NASDAQ:VRTX) Read more
Biotechnology Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers – AnaptysBio (NASDAQ:ANAB) Read more
Biotechnology This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO – Regenxbio (NASDAQ:RGNX) Read more
Biotechnology ARS Pharma Readies Data In Response To FDA’s Rejection For Its EpiPen Alternative For Severe Allergic Reactions – ARS Pharmaceuticals (NASDAQ:SPRY) Read more
Cannabis Aurora Cannabis (ACB): Canaccord Genuity Analysts Say Now’s The Time To Buy. Find Out Why – Aurora Cannabis (NASDAQ:ACB) Read more
Biotechnology Why Is IGM Biosciences Stock Trading Higher Today? – IGM Biosciences (NASDAQ:IGMS) Read more
Biotechnology AbbVie’s Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures – Cerevel Therapeutics Hldg (NASDAQ:CERE), AbbVie (NYSE:ABBV) Read more
Biotechnology Analyst Highlights ‘Rock Solid’ Data For Vera Therapeutics’ Kidney Disease-Targeted Atacicept, Upgrades To Strong Buy – Vera Therapeutics (NASDAQ:VERA) Read more
